Milestone Pharmaceuticals to Present at the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference

Rhea-AI Summary

Milestone Pharmaceuticals (Nasdaq: MIST) has announced that Amit Hasija, CFO, will present at the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference on September 29, 2021, at 10:00 a.m. ET. The presentation will occur virtually, and a live webcast can be accessed on Milestone's website, with an archived replay available afterward. Milestone is developing innovative cardiovascular medicines, including etripamil, which is in Phase 3 for treating paroxysmal supraventricular tachycardia and in Phase 2 for atrial fibrillation.

MONTREAL and CHARLOTTE, N.C., Sept. 22, 2021 /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that Amit Hasija, Chief Financial Officer and Executive Vice President of Corporate Development, will present at the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference on Wednesday, September 29, 2021 at 10:00 a.m. ET. The conference will be held in a virtual meeting format.

A live webcast of the presentation can be accessed in the News & Events section of Milestone's website at www.milestonepharma.com. An archived replay of the webcast will be available on the same website following the presentation.

About Milestone Pharmaceuticals

Milestone Pharmaceuticals Inc. (Nasdaq: MIST), is a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines. Milestone's lead product candidate etripamil is currently in a Phase 3 clinical-stage program for the treatment of paroxysmal supraventricular tachycardia (PSVT) and in a Phase 2 proof-of-concept trial for the treatment of patients with atrial fibrillation and rapid ventricular rate (AFib-RVR). Milestone Pharmaceuticals operates in Canada and the United States. For more information, visit www.milestonepharma.com and follow the Company on Twitter at @MilestonePharma. 

Contact

David Pitts
Argot Partners
212-600-1902
david@argotpartners.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/milestone-pharmaceuticals-to-present-at-the-2021-cantor-fitzgerald-virtual-global-healthcare-conference-301382167.html

SOURCE Milestone Pharmaceuticals, Inc.

FAQ

When will Milestone Pharmaceuticals present at the Cantor Fitzgerald Healthcare Conference?

Milestone Pharmaceuticals will present on September 29, 2021, at 10:00 a.m. ET.

Where can I watch Milestone Pharmaceuticals' presentation?

The presentation can be watched live on Milestone's website in the News & Events section.

What is the focus of Milestone Pharmaceuticals?

Milestone Pharmaceuticals focuses on developing and commercializing innovative cardiovascular medicines.

What is etripamil used for?

Etripamil is being developed for treating paroxysmal supraventricular tachycardia and atrial fibrillation.

What stock symbol represents Milestone Pharmaceuticals?

Milestone Pharmaceuticals is traded under the stock symbol MIST.